NASDAQ : CDIO
-$0.06 (-3.12%)
NASDAQ
Meeshanthini V. Dogan
Biotechnology
Healthcare
CDIO
15
US
USD
0.04
17.15
17.15
15.55
0.00
$14825
350.22
0.68
-0.87
-1.97
-$3.71
-$6.5M
-44771.83%
-44771.83%
-82.27%
-81.62%
-0.59
-0.05
-0.05
3/5
1 Analysts
%
-1.20
1/9
$5.8M
$7.93M
$499.78K
-$6.46M
$13003.0
0.90
0.00
17.15
-82.27%
-83.56%
-122.13%
-110.27%
99 days
| Name | Title |
|---|---|
| Elisa Michael Luqman | Chief Financial Officer & Principal Accounting Officer |
| Meeshanthini Dogan | Co-Founder, Chief Executive Officer & Director |
| Robert A. Philibert | Co-Founder, Chief Medical Officer & Director |
| Timur Dogan | Chief Technology Officer |
No votes yet today — be the first to share your view!
About Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Stock
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017. ...
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
2026-08-05 08:35:00
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. will host an investor conference call on Thursday, August 20, 2026, at 3 p.m. Central Time.
2026-06-24 08:35:00
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced that Atlas Healthcare Physicians (AHP) will cover Cardio Diagnostics' tests, Epi+Gen CHD™ and PrecisionCHD™.
2026-05-27 08:35:00
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will exhibit at four upcoming national benefits conferences.
2026-05-20 08:00:00
AUSTIN, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.
Frequently Asked Questions
What is the current Cardio Diagnostics Holdings, Inc. (CDIO) stock price?
Cardio Diagnostics Holdings, Inc.(NASDAQ:CDIO) stock price is $1.71 in the last trading session. During the trading session, CDIO stock reached the peak price of $7.91 while $0.97 was the lowest point it dropped to. The percentage change in CDIO stock occurred in the recent session was --3.12% while the dollar amount for the price change in CDIO stock was -$0.06.
CDIO's industry and sector of operation?
The NASDAQ listed CDIO is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of CDIO?
Elisa Michael Luqman
| Chief Financial Officer & Principal Accounting Officer
Meeshanthini Dogan
| Co-Founder, Chief Executive Officer & Director
Robert A. Philibert
| Co-Founder, Chief Medical Officer & Director
Timur Dogan
| Chief Technology Officer
|
How many employees does CDIO have?
Number of CDIO employees currently stands at 15. CDIO operates from 311 West Superior Street, Chicago, IL 60654, US.
Link for CDIO official website?
Official Website of CDIO is: https://cdio.ai
How do I contact CDIO?
CDIO could be contacted at phone #855 226 9991 and can also be accessed through its website. CDIO operates from 311 West Superior Street, Chicago, IL 60654, US.
How many shares of CDIO are traded daily?
The average number of CDIO shares traded daily for last 3 months was 68.57K.
What is the market cap of CDIO currently?
The market value of CDIO currently stands at $5.06M with its latest stock price at $1.71